Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate (Q39364951)

11 September 2017

title

Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate (English)

1 reference

11 September 2017

0 references

Guillermo Posadas-Herrera

1

1 reference

11 September 2017

Shingo Inoue

2

1 reference

11 September 2017

Isao Fuke

3

1 reference

11 September 2017

Yuko Muraki

4

1 reference

11 September 2017

Cynthia A Mapua

5

1 reference

11 September 2017

Afjal Hossain Khan

6

1 reference

11 September 2017

Maria Del Carmen Parquet

7

1 reference

11 September 2017

Sadao Manabe

8

1 reference

11 September 2017

Osamu Tanishita

9

1 reference

11 September 2017

Toyokazu Ishikawa

10

1 reference

11 September 2017

Filipinas F Natividad

11

1 reference

11 September 2017

Yoshinobu Okuno

12

1 reference

11 September 2017

Futoshi Hasebe

13

1 reference

11 September 2017

Kouichi Morita

14

1 reference

11 September 2017

language of work or name

English

0 references

publication date

8 October 2010

1 reference

11 September 2017

1 reference

11 September 2017

volume

28

1 reference

11 September 2017

issue

50

1 reference

11 September 2017

page(s)

7939-7946

1 reference

West Nile virus: epidemiology and ecology in North America

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

West Nile virus and North America: an unfolding story.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Epidemiology and transmission dynamics of West Nile virus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

West Nile: worldwide current situation in animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

West Nile virus infection transmitted by blood transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

West Nile virus: a growing concern?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Transmission of West Nile virus from an organ donor to four transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Intrauterine West Nile virus: ocular and systemic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

A live, attenuated recombinant West Nile virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Rapid focus reduction neutralization test of Japanese encephalitis virus in microtiter system. Brief report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.076

10.1016/J.VACCINE.2010.09.076

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference